PeerCurrent.com|Stay current with the people and research shaping what comes next.

Your Feed AI Summary Saved Board Expert Discussion This Week in Your Field

Follows Journals Trials Guidelines Markets

Researcher

Chao Liu

State Key Laboratory of Vaccines for Infectious Diseases, Xiang an Biomedicine Laboratory, and Fujian Provincial Key Laboratory of Innovative Drug Target Research, School of Pharmaceutical Sciences, Xiamen University, Xiamen, 361102, China.

1 development in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

For You Latest Breakthroughs Trials Reviews Guidelines

Latest

Everything in the corpus, newest first.

JUN 27, 2026 · JOURNAL ARTICLE

Immune cell-derived membrane nanovesicles: A promethean fire for autoimmune disease therapy through immune cell mimicry.

Bioactive Materials

This is a narrative review of an emerging nanotechnology platform with preclinical mechanistic concepts and no clinical trial data, raising therapeutic possibilities rather than testing them in humans.

Hypothesis-GeneratingAutoimmune Diseases Targeted Therapy Jimin Zhang

Reported

Global autoimmune disease prevale…approximately 5-10% of the global population

Sex distribution of autoimmune di…more prevalent in women than in men

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support